Published in Medical Letter on the CDC and FDA, August 20th, 2006
As previously disclosed in company filings, Alphatec entered in to a private label distribution agreement with Sea Spine, Inc., for the sale of Sea Spine's Cross Link adjustable bridge product under Alphatec's private label. This FDA clearance will allow Alphatec to begin the immediate commercial sale of its private label adjustable bridge, which will be used in combination with the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.